Biotechnology company Moderna (NASDAQ:MRNA) will be reporting results this Friday before the bell. Here’s what to expect.

CAMBRIDGE, MA / ACCESS Newswire / July 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on its ...

Moderna (Nasdaq: MRNA) has secured European clearance for its latest version of Spikevax (elasomeran) for individuals aged ...

CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

Moderna’s LP.8.1-adapted COVID-19 vaccine has been recommended by the European Medicines Agency (EMA)’s human medicines ...

Although the COVID vaccine does not contain gp145, Dr Krawczyk said it was wrong to suggest it could in any way lead to HIV, ...

In late June, the Scientific Advisory Group for the Origins of Novel Pathogens (SAGO), a group of independent experts ...

There was no credible evidence that Gates has been granted approval, secret or otherwise, to spray RNA (including mRNA, a ...

A study spearheaded by researchers at Stanford Medicine reports a substantial increase in cases of acute necrotizing ...

In the wake of Trump’s global trade war, can the World Trade Organization reclaim its role as guardian of free trade?

Dr. Vinay Prasad had been serving as the FDA's director of the Center for Biologics Evaluation and Research since May, and ...